TipRanks
Advertisement
Advertisement
PharmaMar Grows Recurring Revenue as EU Approval Boosts Zepzelca Outlook
PremiumCompany AnnouncementsPharmaMar Grows Recurring Revenue as EU Approval Boosts Zepzelca Outlook
2M ago
Pharma Mar Board Approves 2026 Half-Year Financial Report
Premium
Company Announcements
Pharma Mar Board Approves 2026 Half-Year Financial Report
2M ago
Pharma Mar Board Appointment Lapses, Governance Structure Unchanged
Premium
Company Announcements
Pharma Mar Board Appointment Lapses, Governance Structure Unchanged
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100